Masimo | MASI - Selling And Administration Expenses

Stock Price
175.50
Daily Change
0.39 0.23%
Monthly
25.17%
Yearly
2.80%
Q1 Forecast
169.67

Masimo reported $116.4M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Accuray USD 127.32M 500.16M Sep/2025
Align Technology USD 441.68M 23.88M Dec/2025
AngioDynamics USD 35.99M 14K Feb/2025
Artivion USD 50.02M 697K Sep/2024
AtriCure USD 78.34M 109K Dec/2025
Avanos Medical USD 77.6M 5.9M Sep/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Globus Medical USD 313.6M 9.98M Sep/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
Masimo USD 116.4M 20.5M Sep/2025
Medtronic 2.97B 159M Sep/2025
Orthofix International USD 112.21M 1.1M Sep/2024
Owens Minor USD 462.35M 30.72M Mar/2025
ResMed USD 278.4M 19.2M Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 281.76M 66.68M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025